EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands

Giuliana Costanzo, Vincenzo Patamia, Rita Turnaturi, Carmela Parenti, Chiara Zagni, Jessica Lombino, Emanuele Amata, Agostino Marrazzo, Lorella Pasquinucci, Antonio Rescifina iD

Chemical Biology & Drug Design · 2023

DOI: 10.1111/cbdd.14220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Giuliana Costanzo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Receptors, Opioid, delta. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università di Catania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

6,7‐Benzomorphans have been investigated in medicinal chemistry for developing new drugs. This nucleus could be considered a versatile scaffold. The physicochemical properties of benzomorphan N ‐substituent are crucial in achieving a definite pharmacological profile at opioid receptors. Thus, the dual‐target MOR/DOR ligands LP1 and LP2 were obtained through N ‐substituent modifications. Specifically, LP2, bearing as N ‐substituent the (2 R / S )‐2‐methoxy‐2‐ phenylethyl group, is a dual‐target MOR/DOR agonist and is successful in animal models of inflammatory and neuropathic pain. To obtain new opioid ligands, we focused on the design and synthesis of LP2 analogs. First, the 2‐methoxyl group of LP2 was replaced by an ester or acid functional group. Then, spacers of different lengths were introduced at N ‐substituent. In‐vitro, their affinity profile versus opioid receptors has been performed through competition binding assays. Molecular modeling studies were conducted to deeply analyze the binding mode and the interactions between the new ligands and all opioid receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, muReceptors, Opioid, deltaAnimalsBenzomorphansLigandsReceptors, OpioidStructure-Activity Relationship

Stichwörter der Autor:innen

6,7-benzomorphandocking studiesopioid receptorradioligand competition-binding

Substanzen

Receptors, Opioid, muReceptors, Opioid, deltaBenzomorphansLigandsReceptors, Opioid

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
  • Department of Drug and Health Sciences, University of Catania, Catania, Italy.

ORCID-Profile: Antonio Rescifina

Förderung

  • Università di Catania

Zitieren

APA

Costanzo, G., Patamia, V., Turnaturi, R., Parenti, C., Zagni, C., Lombino, J., Amata, E., Marrazzo, A., Pasquinucci, L., & Rescifina, A. (2023). Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14220

Vancouver

Costanzo G, Patamia V, Turnaturi R, Parenti C, Zagni C, Lombino J, et al. Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14220

BibTeX
@article{Costanzo2023,
  author = {Costanzo, Giuliana and Patamia, Vincenzo and Turnaturi, Rita and Parenti, Carmela and Zagni, Chiara and Lombino, Jessica and Amata, Emanuele and Marrazzo, Agostino and Pasquinucci, Lorella and Rescifina, Antonio},
  title = {Design, synthesis, in vitro evaluation, and molecular modeling studies of N ‐substituted benzomorphans, analogs of LP2 , as novel MOR ligands},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  doi = {10.1111/cbdd.14220}
}
Kostenlos starten →